Related Experiment Video
Updated: Sep 28, 2025

09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
13.6K
Waldenstrom's Macroglobulinemia and Ascites: A Case Report
Carolina Bologna1, Antonio Cozzolino1, Andrea Ferraro1
1UOC Medicina Generale Ospedale del Mare ASL Na 1, Naples, Italy.
Journal of Blood Medicine
|March 29, 2022
Summary
This case highlights an unusual presentation of Waldenstrom's disease (WM) in an elderly patient, diagnosed via ascites and lymphadenopathy. Treatment with chemotherapy effectively reduced IgM levels and resolved ascites.
Area of Science:
- Hematology
- Oncology
- Internal Medicine
Background:
- Waldenstrom's disease (WM) is a lymphoplasmacytic lymphoma characterized by IgM monoclonal gammopathy and potential hyperviscosity syndrome.
- Typical WM symptoms include fatigue, weight loss, night sweats, and lymphadenopathy, often in patients with a history of monoclonal gammopathy of undetermined significance (MGUS).
- This case presents an atypical initial manifestation of WM, emphasizing diagnostic challenges in elderly patients.
Observation:
- A 73-year-old patient presented with new-onset ascites and an interportocaval lymph node mass, without prior MGUS history.
- Imaging revealed a retrocaval mass, and laboratory tests showed elevated IgM levels (2190 mg/dL) with a monoclonal protein and free kappa chains.
- Bone marrow biopsy confirmed Waldenstrom's disease (type B lymphoproliferative syndrome).
Findings:
- The patient received chemotherapy with Bendamustine (120 mg).
- Within 4 weeks, IgM levels decreased significantly.
- Ascites resolved completely following treatment, indicating therapeutic efficacy.
Implications:
- This case underscores the importance of considering atypical presentations of WM, particularly in the elderly.
- The resolution of ascites suggests a potential link between IgM levels and portal hypertension in WM, warranting further pathogenetic investigation.
- Early diagnosis and prompt treatment are crucial for managing WM and its complications.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
Nephrotic Syndrome I : Introduction
41
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
Nephrotic Syndrome III : Nursing Management
62
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
62

